Thirty two new stemofoline analogues were prepared from didehydrostemofoline for studies as AChE inhibitors. C-3 side-chain modified amino, carbamate, triazole and oxazole stemofoline derivatives were prepared. In general the amine derivatives were found to be stronger inhibitors of AChE than their alcohol analogues that we previously reported. Compounds 5 and 26, with small C-3 side chain substituents, were two of the most active inhibitors. Preliminary molecular docking studies suggested that these compounds may inhibit AChE by binding horizontally along the passage of the active-site gorge and block access to acetylcholine. Corresponding authors: Tel +61-2-42213511; fax: +61-2-42214287 E-mail address: spyne@uow.edu.au
Introduction
One of the primary roles of acetylcholinesterase (AChE) is the hydrolysis of the neurotransmitter acetylcholine (ACh) to inactive choline and acetate in cholinergic synapses.
Thus AChE is essential for the rapid modulation of synaptic acivity. 1 Hydrolysis of ACh occurs through a protease-like action of an active site serine residue. This site resides at the end of a relatively long and narrow gorge. Inhibitors of AChE can bind irreversibly (for example, some pesticides) or reversibly to the active site or at other sites in the gorge (for example, the peripheral anionic site (PAS)) and block the access of ACh to the active site. More recent AD drug development strategies involve targeting microtubule-associated τ-protein, metal ion dyshomeostasis and the various β-amyloid (Aβ) pathological mechanisms of this disease. 2, 3 AChE colocalizes with Aβ which then promotes and accelerates Aβ aggregation. [4] [5] [6] This has renewed an intense interest in AChE inhibitors, including dual binding AChE inhibitors 7 and those that can be activated by AChE 8 and have Aβ-antiaggregating action. We have recently reported that the Stemona alkaloids stemofoline and didehydrostemofoline and some of their C-3 side chain derivatives are inhibitors of AChE. [9] [10] [11] Such activity is most likely associated with the insecticidal activity of these alkaloids and the crude extracts of Stemona plants. Our earlier studies focused on C-3 hydroxyalkyl derivatives, including the synthesis of rare Stemona alkaloids, where it was found that the AChE inhibitory activity was dependent upon the length of the C-3 alkyl chain, the position of the hydroxyl group and in some cases the configuration of the carbinol carbon. 10 This study also revealed that the butyrolactone ring of stemofoline was essential for AChE inhibitory activity. 10 We report here the synthesis of several novel C-3 side-chain amino, carbamate, triazole and oxazole stemofoline derivatives and their activities as AChE inhibitors.
Results and discussion

Synthesis of compounds
In order to prepare the amine derivatives 3-19, the known aldehyde 2 was prepared from didehydrostemofoline 1 (Figure 1 ), following our previously described procedures 9 and used as a key scaffold for reductive amination reactions to prepare the 17 amine derivatives as shown in Scheme 1. Another key scaffold, the alkyne 26, was prepared from a one-step alkynylation reaction 14 of the aldehyde 2 using the Bestmann-Ohira reagent 15, 16 (dimethyl-1-diazo-2-oxopropylphosphonate) which was prepared as described by Ghosh et. al.
(Scheme 5).
The 1,3-dipolar cyclization ("click") reactions of the alkyne 26 (Scheme 6) were examined under three different reaction conditions to provide the four triazoles 27-30 and the two isoxazoles 31-32 in yields ranging from 18-59%. The alkyne 26 was treated under Sonogashira coupling conditions 18 to yield the phenyl substituted alkyne 33 in 62% yield and the self-condensation product 34 in 4% yield (Scheme 7 (i)). The dimer 34 was more effectively obtained in 89% yield under Eglington coupling conditions 19 (Scheme 7 (ii)). The Sonogashira product 33 was hydrogenated over Pd/C under a H 2 atmosphere for 24 h to give the reduced product 35 in 74% yield (Scheme 7 (iii)). 
Biological assays
We initially used the TLC bioautographic method of Hostettmann 20 to determine the minimum inhibitory requirements (MIRs) of these compounds against electric eel AChE (eeAChE) using galanthamine as a positive control. The results are reported in Tables 1−3 . In our assay, galanthamine had a MIR of 1 ng. This assay revealed that the carbamate 22 and the tertiary amino compound 4 (Table 1, entries 1 and 2) were essentially equipotent to galanthamine and more potent than their parent compound didehydrostemofoline 1. The secondary amino compounds 19, 5 and 3 and the guanidine derivative 25 were equipotent to didehydrostemofoline 1 (Table 1, (Table 1, entries 8−18 ). The dibasic-amino compounds 11 and 17 were the least active amine derivatives (Table 1, entries 22 and 23) . None of the click products 27−32 (Table 2) were as potent as didehydrostemofoline 1 or the amino derivatives in Table 1 , entries 1−7.
The N-benzyl-triazole derivative 27 was the most potent of this series of compounds while the others with longer and more flexible linkers (28 and 30) or no linker (29, 31 and 32) between the heterocyclic triazole or isoxazole moiety and the aryl substituent were significantly less active.
The terminal alkyne 26 and the phenylethyl derivative 35 were essentially equipotent to galanthamine and didehydrostemofoline 1, respectively (Table 3 , entries 1 and 2).
Substitution of the terminal alkyne CH of 26 with a phenyl group, as in compound 33, had an adverse effect on inhibitory activity. The dimer of 26 had very poor activity (Table 3) .
Compared to our earlier results, 10 this study showed that in general the amine derivatives were more active than our previously reported alcohol derivatives. 10 We attempted to determine the IC 50 values of many of the more active compounds, and some of the alcohol analogues we reported earlier, 10 against eeAChE and human AChE (hAChE) using Ellman's assay. 21 We found however, that the majority of these compounds were not soluble in the assay medium (DMSO, pH 7.0 phosphate buffer). The IC 50 results determined on those that were soluble in the assay medium are shown in Table 4 . In our assay, galanthamine had IC 50 values of 0.912 µM and 0.597 µM against eeAChE and hAChE, respectively (Table 4 , entry 1). Didehydrostemofoline 1 and compound 5, which both had MIRs of 5 ng against eeAChE, showed similar IC 50 values (ca 12−25 µM) against eeAChE and hAChE, which indicated they were significantly less potent than galanthamine ( To inhibit AChE, inhibitors can bind to one or more sites of the enzyme. AChE has been reported to have at least two binding sites, the active site and the peripheral anionic site (PAS).
22
The active site is buried at the bottom of a 20 Å deep narrow gorge 23 and includes four catalytic subsites, the esteractic site (which contains Ser200, His440 and Glu327), the oxyanion hole (which contains Gly118, Gly119 and Ala201), the acyl pocket (which contains Phe288 and Phe290) and the anionic subsite (which contains Trp84, Phe330 and Glu199). 24 In contrast, the PAS which consists of Tyr70, Asp72, Tyr121, Tyr334 and Trp279, is located at the entrance of the active-site gorge. The binding of ligands to the PAS may block the passage of ACh or change the conformation of the active site allosterically and inhibit its function. 24 Preliminary molecular docking studies using GOLD suite versions 4.1 and 5.0 (CCDC, Cambridge, UK) 25 indicated that the more potent derivatives 5 and 26, having small side chains, fitted "horizontally" in the active site while those with longer side chains (for example, 33) fitted only "vertically" into the active-site gorge (Figure 1 ). Further studies to understand the mode of action of these compounds are in progress. In conclusion, thirty two new stemofoline analogues were prepared to study as AChE inhibitors. In general the amine derivatives were found to be stronger inhibitors of AChE than their alcohol analogues that we previously reported. . Prepared using the general method described above, using the aldehyde 2 (24.3 mg, 0.068 mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), isopropylamine (11.6 µL, 0.135 mmol) and NaBH(OAc) 3 . Prepared using the general method described above, using the aldehyde 2 (26.6 mg, 0.074 mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), ethyl 1-piperazinecarboxylate (22.0 µL, 0.148 mmol) and NaBH(OAc) 3 (12) . Prepared using the general method described above, using the aldehyde 2 (15.9 mg, 0.044 mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), aniline (13.2 µL, 0.089 mmol) and NaBH(OAc) 3 1.12 (5Z)-5-[(2S,2aR,6S,7aS,7bR,8R,9S)-Hexahydro-7b-1-(Ncyclopropylmethylaminomethyl)-9-methyl-4H-2 5-[(2S,2aR,6S,7aS,7bR,8R,9S) 5-[(2S,2aR,6S,7aS,7bR,8R,9S)-Hexahydro-7b-1-(N-cyclohexylaminomethyl)- 
(5Z)-5-[(2S,2aR,6S,7aS,7bR,8R,9S)-Hexahydro
3.
(5Z)-
9-methyl-4H-2,2,6-(epoxy[1]propanyl[3]ylidene)furo[2,3,4-gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (17).
Prepared using the general method described above, using the aldehyde 2 (23.2 mg, 0.065 mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), cyclohexylamine (15.0 µL, 0.129 mmol) and NaBH(OAc) 3 
(5Z)-5-[(2S,2aR,6S,7aS,7bR,8R,9S)-Hexahydro-7b-1-[N-(2S-phenylethyl)aminomethyl]-9-methyl-4H-2,2,6-(epoxy[1]propanyl[3]ylidene)furo[2,3,4-
gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (18).
Prepared using the general method described above, using the aldehyde 2 (29.7 mg, 0.083 mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), (S)-1-aminoethylbenzene (21.3 µL, 0.165 mmol) and NaBH(OAc) 3 5-[(2S,2aR,6S,7aS,7bR,8R,9S)-Hexahydro-7b-1-[N-(2R-phenylethyl)aminomethyl]-9-methyl-4H-2,2,6-(epoxy[1]propanyl[3]ylidene)furo[2,3,4-gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (19) . Prepared using the general method described above, using the aldehyde 2 (30.9 mg, 0.086 mmol), dichloroethane (2.0 mL), acetic acid (0. 
(5Z)-
Methylation reaction: Preparation of (5Z)-5-[(2S,2aR,6S,7aS,7bR,8R,9S)-hexahydro-7b-1-(N-methyl-N-allylaminomethyl)-9-methyl-4H-2,2,6-(epoxy[1]propanyl[3]ylidene)furo[2,3,4-gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-
2(5H)-furanone (20).
Prepared using the general method described above, using formaldehyde solution (ca. 400g/L, 3.75 µL, 0.245 mmol) as the aldehyde component, dichloroethane (2.0 mL), acetic acid (0.2 mL), the amine 6 (9.8 mg, 0.024 mmol) as the amine component and NaBH(OAc) 3 s, 3H, H-16), 1.94 (d, J 12.0 Hz, 1H, H-1a), 1.91-1.81 (m, 2H, H-6 5-[(2S,2aR,6S,7aS,7bR,8R,9S)-Hexahydro-7b-1-(N-ethoxycarboxyl-Ncyclopentylaminomethyl)-9-methyl-4H-2,2,6-(epoxy[1]propanyl[3]ylidene)furo[2,3,4-gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (22) . Prepared using the general method described above, using the amine 16 (11.2 mg, 0.026 mmol) 2:1 THF/saturated aqueous NaHCO 3 solution (3.0 mL) and ethyl chloroformate (5.0 µL, 0.052 mmol). The purified product was obtained as a yellow gum (7.3 mg, 0.015 mmol, 56% yield). 5-[(2S,2aR,6S,7aS,7bR,8R,9S)-Hexahydro-7b-1-(N-ethoxycarboxyl-N 5-[(2S,2aR,6S,7aS,7bR,8R,9S 5-[(2S,2aR,6S,7aS,7bR,8R,9S) 5-[(2S,2aR,6S,7aS,7bR,8R,9S 5-[(2S,2aR,6S,7aS,7bR,8R,9S)-hexahydro-7b-1-(1-benzyl-1H-1,2,3-triazol-4-yl)-9-methyl-4H-2 5-[(2S,2aR,6S,7aS,7bR,8R,9S)-Hexahydro-7b-[1-(3-phenylpropyl)-1H-1,2,3 5-[(2S,2aR,6S,7aS,7bR,8R,9S)-Hexahydro-7b-1-[3-(2-propylisoindoline-1,3-dionyl)-1H-1,2,3-triazol-4-yl]-9-methyl-4H-2 at rt was added N-hydroxybenzenecarboximidoyl chloride (10 mg, 0.064 mmol) and sodium hydroxide (2.6 mg, 0.064 mmol). The reaction was left to stir for 3 h. The mixture was quenched with saturated aqueous NaHCO 3 solution (10 mL) and was directly extracted with CH 2 Cl 2 (3 × 20 mL). The combined organic extracts were washed with brine and dried (MgSO 4 ) before being concentrated in vacuo. The concentrated residue was purified by column chromatography using gradient elution from CH 2 Cl 2 to CH 2 Cl 2 /MeOH (9:1) to give a white gum (11.9 mg, 0.025 mmol, 59% yield). R f = 0.37 in MeOH/EtOAc (1:9 96 (m, 3H, H-1a, H-6 5-[(2S,2aR,6S,7aS,7bR,8R,9S 5-[(2S,2aR,6S,7aS,7bR,8R,9S)-Hexahydro-7b-1-(2-phenylethyl) 
(5Z)-
Guanidination reaction: Preparation of (5Z)-
(5Z)-
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AChE inhibition studies
TLC Bioautographic method
The AChE used in this assay was extracted from electric eels and purchased from Sigma Aldrich (EC 3.1.1.7). The enzyme stock solution was prepared from a solution of AChE (1000 U) in 0.05 M tris-hydrochloric acid buffer (150 mL) at pH 7.8 to which was added bovine serum albumin (150 mg) to stabilize the enzyme. The stock solution was kept at 4 °C. 
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